Trial
NCT03589976
A Futility Trial of Sirolimus in Multiple System Atrophy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Condition
Multiple System Atrophy
Intervention
Sirolimus 2 MG
Why stopped
Interim analysis showed early evidence of futility of sirolimus. Trial stopped per DSMB recommendation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-07